Answers are grounded in this paper and cite their sources.
This review mainly focused on methods that are used for identifying novel bacterial antigens that can use in recombinant subunit vaccine development. Particularly, it describes the processes involved in reverse vaccinology, genomic function, bioinformatics and immunological approaches and some associated complementary technologies such as proteomics that can be used in identification of new and potentially useful vaccine antigens. Results obtained from the application of these methods are forming basis for a new generation of vaccine for use in the control of bacterial infections of humans and animals.
No takes yet. Share an insight, caveat, or question.
Halo Yohans (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: